Detalhe da pesquisa
1.
KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma.
Future Oncol
; 17(22): 2847-2855, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33975465
2.
KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancer.
Future Oncol
; 15(9): 943-952, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30777447
3.
A phase I study of TRC105 anti-endoglin (CD105) antibody in metastatic castration-resistant prostate cancer.
BJU Int
; 116(4): 546-55, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25407442
4.
Pembrolizumab Plus Binimetinib With or Without Chemotherapy for MSS/pMMR Metastatic Colorectal Cancer: Outcomes From KEYNOTE-651 Cohorts A, C, and E.
Clin Colorectal Cancer
; 23(2): 183-193, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38653648
5.
Pembrolizumab Plus mFOLFOX7 or FOLFIRI for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer: KEYNOTE-651 Cohorts B and D.
Clin Colorectal Cancer
; 23(2): 118-127.e6, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38762348
6.
Olaparib with or without bevacizumab versus bevacizumab plus a fluoropyrimidine as maintenance therapy in advanced colorectal cancer: The randomized phase 3 LYNK-003 study.
Eur J Cancer
; 205: 114036, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38749110
7.
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study.
J Clin Oncol
; : JCO2302736, 2024 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38833658
8.
Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer.
BJU Int
; 111(8): 1269-80, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23419134
9.
Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials.
JAMA Oncol
; 7(6): 895-902, 2021 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33792646
10.
A SNP in CYP2C8 is not associated with the development of bisphosphonate-related osteonecrosis of the jaw in men with castrate-resistant prostate cancer.
Ther Clin Risk Manag
; 6: 579-83, 2010 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-21151627
11.
Emergencies related to cancer chemotherapy and hematopoietic stem cell transplantation.
Emerg Med Clin North Am
; 27(2): 311-31, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19447314